A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data Assumptions

It is critical to evaluate the sensitivity of conclusions from a clinical trial to potential violations in the missing data assumptions of the statistical analysis. Sensitivity analyses should not consist of a few methods that might have been reasonable alternatives to the chosen analysis method, nor should they explore only a limited space of violations in the assumptions of the analysis. Instead, sensitivity analyses should target the same estimand as that targeted in the main analysis, and they should systematically and comprehensively explore the space of possible assumptions to evaluate whether the key conclusions hold up under all plausible scenarios. In a randomized, controlled trial, this can be achieved by tipping point analyses that vary assumptions about missing outcomes on the experimental and control arms to identify and discuss the plausibility of scenarios under which there is no longer evidence of a treatment effect. We introduce a simple, novel tipping point approach in which, for a variable that is quantitative or can be analyzed as if it is quantitative, inference on the treatment effect is based on the observed data and two sensitivity parameters, with minimal assumptions and no need for imputation. The sensitivity parameters to be varied are the mean differences between outcomes in dropouts and outcomes in completers on each of the two treatment arms. We derive the asymptotic properties of the proposed statistic and illustrate the utility of such an approach with two examples of drug reviews in which the methodology was utilized to inform regulatory decision-making.

Authors

Institutions

Publication Details

Journal
Pharmaceutical Statistics
Published
2025-03-26
DOI
https://doi.org/10.1002/pst.70002
Citations
3
Primary Topic
Statistical Methods in Clinical Trials
Type
article
Field-Weighted Citation Impact
7.89
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data Assumptions

Rebecca Chiu, Daniel B. Rubin, William Koh, Thomas Permutt et al.
3 citations
Pharmaceutical Statistics
Statistical Methods in Clinical Trials
7.89
article

A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data Assumptions

Rebecca Chiu, Daniel B. Rubin, William Koh, Thomas Permutt, C. Torres, Gregory Levin
article en
3 citations

Abstract

It is critical to evaluate the sensitivity of conclusions from a clinical trial to potential violations in the missing data assumptions of the statistical analysis. Sensitivity analyses should not consist of a few methods that might have been reasonable alternatives to the chosen analysis method, nor should they explore only a limited space of violations in the assumptions of the analysis. Instead, sensitivity analyses should target the same estimand as that targeted in the main analysis, and they should systematically and comprehensively explore the space of possible assumptions to evaluate whether the key conclusions hold up under all plausible scenarios. In a randomized, controlled trial, this can be achieved by tipping point analyses that vary assumptions about missing outcomes on the experimental and control arms to identify and discuss the plausibility of scenarios under which there is no longer evidence of a treatment effect. We introduce a simple, novel tipping point approach in which, for a variable that is quantitative or can be analyzed as if it is quantitative, inference on the treatment effect is based on the observed data and two sensitivity parameters, with minimal assumptions and no need for imputation. The sensitivity parameters to be varied are the mean differences between outcomes in dropouts and outcomes in completers on each of the two treatment arms. We derive the asymptotic properties of the proposed statistic and illustrate the utility of such an approach with two examples of drug reviews in which the methodology was utilized to inform regulatory decision-making.

Pharmaceutical StatisticsVol. 24(3)
United States Food and Drug Administration (US)
Peace, Justice and strong institutions
Openalex Percentile: Top 3%
Statistical Methods in Clinical Trials
7.89
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data Assumptions — Rebecca Chiu, Daniel B. Rubin, et al. · Pharmaceutical Statistics (2025) | TGRS Research Map | TGRS